title: [Macroglobulin family proteins in breast cancer].
abstract: Determined serum levels of alpha-2-macroglobulin (a2-MG) and pregnancy-associate alpha-2-glycoprotein (a2-PAG) in 98 breast cancer patients stage I-IV prior to the special antitumor treatment. Statistically significant negative correlative dependence of the a2-PAG in the blood and lifetime of patients is proved. We believe that the definition of pre-treatment level of a serum a2-MG and a2-PAG concentrations for patients with breast cancer, can be used as an additional predictor of life expectancy.
authors.forename: N V
authors.initials: NV
authors.lastname: Promzeleva
authors.forename: V N
authors.initials: VN
authors.lastname: Zorina
authors.forename: N A
authors.initials: NA
authors.lastname: Zorin
mesh_terms: D014408:Biomarkers, Tumor / Q000097:blood*; D001943:Breast Neoplasms / Q000097:blood* / Q000473:pathology; D005260:Female; D006801:Humans; D008017:Life Expectancy; D008875:Middle Aged; D009367:Neoplasm Staging; D011237:Predictive Value of Tests; D045384:Pregnancy-Associated alpha 2-Macroglobulins / Q000378:metabolism*; D011379:Prognosis; D000511:alpha-Macroglobulins / Q000378:metabolism*
chemical_list: D014408:Biomarkers, Tumor; D045384:Pregnancy-Associated alpha 2-Macroglobulins; D000511:alpha-Macroglobulins